|
|
||||||||
|
FIGURE 2. 18F-FDG incorporation by control MCF-7 cells (n = 7) treated for 30 min (n = 7) and 3.5 h (n = 4) with valinomycin (% control).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |